Anacor Pharmaceuticals Announces Third Quarter 2011 financial Results ... FierceBiotech In addition, Anacor is nonindustrial AN2718 as a topical antifungal product candidate for the treatment of onychomycosis and skin fungal infections, and AN2898 as type A topical anti-inflammatory product nominee for the treatment of psoriasis and atopic ... and more » Link To Article
No comments:
Post a Comment